Bottom price Rivaroxaban - Ursodeoxycholic acid 128-13-2 Digestive system Cholagogic – Neore
Bottom price Rivaroxaban - Ursodeoxycholic acid 128-13-2 Digestive system Cholagogic – Neore Detail:
Payment: T/T, L/C
Product Origin: China
Shipping Port: Beijing/Shanghai/Hangzhou
Production capacity: 2000kg/month
Order(MOQ): 25kg
Lead Time: 3 Working Days
Storage condition: Stored in cool, dry place, room temperature.
Package material: drum
Package size: 25kg/drum
Safety information: Not dangerous goods
Introduction
Ursodeoxycholic acid (UDCA), also known as ursodiol, is a secondary bile acid, produced in humans and most other species from metabolism by intestinal bacteria. It is synthesized in the liver in some species, and was first identified in bear bile, which is the derivation of its name Ursus. In purified form, it has been used to treat or prevent several diseases of the liver or bile ducts.
UDCA has been used as medical therapy in gallstone disease (cholelithiasis) and for biliary sludge. UDCA helps reduce the cholesterol saturation of bile and leads to gradual dissolution of cholesterol-rich gallstones.
UDCA may be given after bariatric surgery to prevent cholelithiasis, which commonly occurs due to the rapid weight loss producing biliary cholesterol oversaturation and also biliary dyskinesia secondary hormonal changes.
Specification (EP10)
|
Item |
Specification |
|
Appearance |
White or almost white powder |
|
Solubility |
Practically insoluble in water, freely soluble in ethanol (96%), slightly soluble in acetone, practically insoluble in methylene chloride |
| Melting point |
202-204℃ |
|
Identification |
Same IR spectrum as ursodeoxycholic acid CRS |
| The principal spot in the chromatogram obtained with the test solution (b) is similar in position, colour and size to the principle spot in the chromatogram obtained with reference solution (a). | |
| The suspension obtained is greenish-blue. | |
| Specific optical rotation |
+58.0~+62.0° |
| Impurity C |
Lithocholic acid ≤ 0.1% |
| Related substance (HPLC) |
impurity A: chenodeoxycholic acid ≤ 1.0% |
|
unspecified impurities ≤ 0.1% |
|
|
total ≤ 1.5% |
|
| Heavy metals |
ICH Q3D |
|
Loss on drying |
≤ 1.0% |
| Sulphated ash |
≤ 0.1% |
| Assay |
99.0%~101% (Dried substance) |
| Residual solvents |
Acetone ≤ 5000 ppm Ethyl acetate ≤ 5000 ppm Isopropanol ≤ 5000 ppm Ethanol ≤ 5000 ppm |
| Microbiological Tests |
Total aerobic microbial count ≤ 10³CFU/g Total yeasts and moulds count ≤ 10²CFU/g Escherichia coli: Absent in 1 g Salmonella: Absent in 10 g |
| Additional properties | |
| Particle size distribution |
100% pass number 180 sieve (100% pass 80 mesh sieve) |
Product detail pictures:
Related Product Guide:
High quality Initial,and Buyer Supreme is our guideline to offer the ideal assistance to our shoppers.At present, we are striving our best to become amongst the ideal exporters inside our industry to satisfy shoppers more want for Bottom price Rivaroxaban - Ursodeoxycholic acid 128-13-2 Digestive system Cholagogic – Neore , The product will supply to all over the world, such as: Swaziland, Accra, South Korea, Our company upholds the spirit of "innovation, harmony, team work and sharing, trails, pragmatic progress". Give us a chance and we will prove our capability. With your kind help, we believe that we can create a bright future with you together.
By Alexia from Estonia - 2018.10.31 10:02
The company can think what our think, the urgency of urgency to act in the interests of our position, can be said this is a responsible company, we had a happy cooperation!
By Ann from Azerbaijan - 2018.09.12 17:18
